Terms: = Bone cancer AND ARHGEF12, Q9NZN5, 23365, ENSG00000196914, KIAA0382, LARG, DKFZp686O2372, PRO2792 AND Treatment
3 results:
1. Mesoporous polydopamine-coated hydroxyapatite nano-composites for ROS-triggered nitric oxide-enhanced photothermal therapy of osteosarcoma.
Wang YC; Dai HL; Li ZH; Meng ZY; Xiao Y; Zhao Z
J Mater Chem B; 2021 Sep; 9(36):7401-7408. PubMed ID: 34551050
[TBL] [Abstract] [Full Text] [Related]
2. Therapy-induced Deletion in 11q23 Leading to Fusion of
Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
[TBL] [Abstract] [Full Text] [Related]
3. arhgef12 regulates erythropoiesis and is involved in erythroid regeneration after chemotherapy in acute lymphoblastic leukemia patients.
Xie Y; Gao L; Xu C; Chu L; Gao L; Wu R; Liu Y; Liu T; Sun XJ; Ren R; Tang J; Zheng Y; Zhou Y; Shen S
Haematologica; 2020 Apr; 105(4):925-936. PubMed ID: 31467124
[TBL] [Abstract] [Full Text] [Related]
